ML18016A955: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
 
(One intermediate revision by the same user not shown)
Line 3: Line 3:
| issue date = 01/16/2018
| issue date = 01/16/2018
| title = Nwmi Commission Hearing Exhibit-R List - Final
| title = Nwmi Commission Hearing Exhibit-R List - Final
| author name = Haass C C
| author name = Haass C
| author affiliation = Northwest Medical Isotopes, LLC
| author affiliation = Northwest Medical Isotopes, LLC
| addressee name =  
| addressee name =  
Line 16: Line 16:


=Text=
=Text=
{{#Wiki_filter:Exhibit List (Docket No.
{{#Wiki_filter:Exhibit List-R UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION
50-609-CP)  1 UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION
                                                            )
  ) In the Matter of ) Docket No.
In the Matter of                                         )       Docket No. 50-609-CP
50-609-CP ) NORTHWEST MEDICAL ISOTOPES, LLC
                                                            )
) ) (Medical Radioisotope Production Facility) ) January 1 6, 2018   ) EXHIBIT LIST (R E V I S I O N 1) NORTHWEST MEDICAL ISOTOPES, LLC EVIDENTIARY HEARING
NORTHWEST MEDICAL ISOTOPES, LLC                           )
                                                            )
(Medical Radioisotope Production Facility)               )       January 16, 2018
                                                            )
EXHIBIT LIST (REVISION 1)
NORTHWEST MEDICAL ISOTOPES, LLC EVIDENTIARY HEARING In accordance with the Commissions notice dated November 21, 2017 and Scheduling Order dated January 9, 2018, Northwest Medical Isotopes, LLC (NWMI) hereby submits its list of exhibits for the evidentiary hearing for Docket No. 50-609-CP to be held on January 23, 2018 (Revision 1). As directed by the Scheduling Order, NWMI is re-filing its responses to the Commissions pre-hearing questions (Exhibits NWMI-001-R and NWMI-002-R), supporting exhibits (Exhibits NWMI-003-R through NWMI-007-R), and testimony (Exhibit NWMI-011-R).
NWMI did make one correction to Exhibit NWMI-001in the response to Question 8(e) and modified the dates. NWMI did not alter Exhibit NWMI-002 from the earlier version, except to add the required Business Sensitive and Proprietary header and modify the dates. NWMI did not alter Exhibit NWMI-003-R, except for an update to Michael R. Corums statement of qualifications.
NWMI did not alter Exhibits NWMI-004-R through NWMI-007-R, except to move the exhibit number to the upper right corner and modify the presentation title to match the Scheduling Note provided to NWMI on January 9, 2018. NWMI did make several corrections to Exhibit NWMI-011-R from the earlier version, including a correction to a referenced document number, the deletion of an incorrect meeting reference, and to change the dates.
Exhibit List (Docket No. 50-609-CP)                                                                    1


Exhibit List (Docket No.
Exhibit List-R Below is a crosswalk identifying the NWMI Exhibit number with the corresponding Sponsoring Witness(es) and Document Title.
50-609-CP)  2 Exhibit Number Panel Number/
Exhibit                   Panel Number/
Sponsoring Witness(es)
Number              Sponsoring Witness(es)                 Document Description/Title NWMI-001-R        Carolyn C. Haass                      Northwest Medical Isotopes, LLC Responses to Commissions Public Pre-Hearing Questions NWMI-002-R        Carolyn C. Haass                      Northwest Medical Isotopes, LLC Responses to Commissions Non- Public Pre-Hearing Questions NWMI-003-R        Statement of Qualifications:          Statement of Qualifications in Support of Roy W. Brown, Ralph A. Butler,        Northwest Medical Isotopes, LLC Medical Michael R. Corum, Gary L. Dunford,    Radioisotope Production Facility Construction Nicholas F. Fowler, Carolyn C. Haass, Permit Application Steve R. Reese NWMI-004-R        Overview Panel: Roy W. Brown,        Northwest Medical Isotopes, LLC Nicholas F. Fowler, Carolyn C. Haass, Presentation Slides: Overview Presentation Steve R. Reese NWMI-005-R        Safety Panel 1: Ralph A. Butler,      Northwest Medical Isotopes, LLC Michael R. Corum, Gary L. Dunford,    Presentation Slides: Safety 1 Presentation Carolyn C. Haass, Steve R. Reese NWMI-006-R        Safety Panel 2: Michael R. Corum,    Northwest Medical Isotopes, LLC Gary L. Dunford, Carolyn C. Haass,    Presentation Slides: Safety 2 Presentation Steve R. Reese NWMI-007-R        Environmental Panel: Michael R.      Northwest Medical Isotopes, LLC Corum, Gary L. Dunford, Carolyn C. Presentation Slides: Environmental Haass, Steve R. Reese                Presentation NWMI-008          Letters of Support: U.S. Senators    Federal, State of Missouri, City of Columbia, Ron Wyden and Claire McCaskill;      and Boone County letters of support for the Boone County Commissioner            construction and operation of the Northwest Dan Atwill; Manager, City of          Medical Isotopes, LLC Radioisotope Columbia, Missouri, Mike Mathis;      Production Facility Missouri Department of Economic Development, Terrance M. Maglich, Project Manager NWMI-009          Missouri Department of Natural        Clean Water Act Section 401 Water Quality Resources Letter to Northwest Medical Certification of Northwest Medical Isotopes, Isotopes, LLC, dated September 15,    LLC Facility in Boone County, NUREG-2017                                  2209/CEK007189 Exhibit List (Docket No. 50-609-CP)                                                                    2
Document Description/Title Northwest Medical Isotopes, LLC - Public Pre-Hearing Questions


Exhibit List (Docket No.
Exhibit List-R Exhibit                 Panel Number/
50-609-CP)  3 Exhibit Number Panel Number/
Number              Sponsoring Witness(es)                   Document Description/Title NWMI-010          Northwest Medical Isotopes, LLC        Exemption Request Pursuant to 10 CFR Letter (NWMI-LTR-2017-016) to U.S. 70.17, from Requirement of 10 CFR Nuclear Regulatory Commission, dated  70.21(f), Filing, for Northwest Medical December 18, 2017                      Isotopes, LLC Radioisotope Production Facility, dated December 18, 2017 NWMI-011-R        Carolyn C. Haass                      Applicants Pre-Filed Testimony of Carolyn C. Haass for the Mandatory Hearing on Uncontested Issues for the Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility Respectfully submitted, Executed in Accord with 10 C.F.R. § 2.304(d)
Sponsoring Witness(es)
Carolyn              Digitally signed by Carolyn C Haass C Haass              Date: 2018.01.16 13:27:56 -07'00' Signed (electronically) by Carolyn C. Haass Carolyn C. Haass Northwest Medical Isotopes, LLC - Chief Operating Officer 815 NW 9th Ave, Suite 256 Corvallis, OR 97330 Phone: 509-430-6921 Email: carolyn.haass@nwmedicalisotopes.com Dated in Denver, Colorado this 16th day of January 2018 Exhibit List (Docket No. 50-609-CP)                                                                    3
Document Description/Title Executed in Accord with 10 C.F.R. § 2.304(d)


Certificate of Service (Docket No.
Exhibit List-R UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION
50-609-CP)  UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION
                                                                )
  ) In the Matter of ) Docket No.
In the Matter of                                             )       Docket No. 50-609-CP
50-609-CP ) NORTHWEST MEDICAL ISOTOPES, LLC
                                                                )
) ) (Medical Radioisotope Production Facility) ) January 1 6, 2018   ) CERTIFICATE OF SERVICE Executed in Accord with 10 C.F.R. § 2.304(d)}}
NORTHWEST MEDICAL ISOTOPES, LLC                             )
                                                                )
(Medical Radioisotope Production Facility)                   )       January 16, 2018
                                                                )
CERTIFICATE OF SERVICE I hereby certify that on this date, a copy of the Exhibit List (Revision 1), Northwest Medical Isotopes, LLC, Evidentiary Hearing and Exhibits NWMI-001-R through NWMI-007-R and NWMI-011-R were submitted through the NRC E-filing system.
Exhibits NWMI-007, NWMI-008, and NWMI-009 have not been revised since the original submission on December 29, 2017.
Respectfully submitted, Executed in Accord with 10 C.F.R. § 2.304(d)
Carolyn C Digitally                signed by Carolyn C Haass Haass                    Date: 2018.01.16 13:28:16 -07'00' Signed (electronically) by Carolyn C. Haass Carolyn C. Haass Northwest Medical Isotopes, LLC - Chief Operating Officer 815 NW 9th Ave, Suite 256 Corvallis, OR 97330 Phone: 509-430-6921 Email: carolyn.haass@nwmedicalisotopes.com Dated in Denver, Colorado this 16thday of January 2018 Certificate of Service (Docket No. 50-609-CP)}}

Latest revision as of 05:36, 22 October 2019

Nwmi Commission Hearing Exhibit-R List - Final
ML18016A955
Person / Time
Site: Northwest Medical Isotopes
Issue date: 01/16/2018
From: Haass C
Northwest Medical Isotopes
To:
NRC/OCM
SECY RAS
References
50-609-CP, Construction Permit Mndtry Hrg, RAS 54171
Download: ML18016A955 (4)


Text

Exhibit List-R UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION

)

In the Matter of ) Docket No. 50-609-CP

)

NORTHWEST MEDICAL ISOTOPES, LLC )

)

(Medical Radioisotope Production Facility) ) January 16, 2018

)

EXHIBIT LIST (REVISION 1)

NORTHWEST MEDICAL ISOTOPES, LLC EVIDENTIARY HEARING In accordance with the Commissions notice dated November 21, 2017 and Scheduling Order dated January 9, 2018, Northwest Medical Isotopes, LLC (NWMI) hereby submits its list of exhibits for the evidentiary hearing for Docket No. 50-609-CP to be held on January 23, 2018 (Revision 1). As directed by the Scheduling Order, NWMI is re-filing its responses to the Commissions pre-hearing questions (Exhibits NWMI-001-R and NWMI-002-R), supporting exhibits (Exhibits NWMI-003-R through NWMI-007-R), and testimony (Exhibit NWMI-011-R).

NWMI did make one correction to Exhibit NWMI-001in the response to Question 8(e) and modified the dates. NWMI did not alter Exhibit NWMI-002 from the earlier version, except to add the required Business Sensitive and Proprietary header and modify the dates. NWMI did not alter Exhibit NWMI-003-R, except for an update to Michael R. Corums statement of qualifications.

NWMI did not alter Exhibits NWMI-004-R through NWMI-007-R, except to move the exhibit number to the upper right corner and modify the presentation title to match the Scheduling Note provided to NWMI on January 9, 2018. NWMI did make several corrections to Exhibit NWMI-011-R from the earlier version, including a correction to a referenced document number, the deletion of an incorrect meeting reference, and to change the dates.

Exhibit List (Docket No. 50-609-CP) 1

Exhibit List-R Below is a crosswalk identifying the NWMI Exhibit number with the corresponding Sponsoring Witness(es) and Document Title.

Exhibit Panel Number/

Number Sponsoring Witness(es) Document Description/Title NWMI-001-R Carolyn C. Haass Northwest Medical Isotopes, LLC Responses to Commissions Public Pre-Hearing Questions NWMI-002-R Carolyn C. Haass Northwest Medical Isotopes, LLC Responses to Commissions Non- Public Pre-Hearing Questions NWMI-003-R Statement of Qualifications: Statement of Qualifications in Support of Roy W. Brown, Ralph A. Butler, Northwest Medical Isotopes, LLC Medical Michael R. Corum, Gary L. Dunford, Radioisotope Production Facility Construction Nicholas F. Fowler, Carolyn C. Haass, Permit Application Steve R. Reese NWMI-004-R Overview Panel: Roy W. Brown, Northwest Medical Isotopes, LLC Nicholas F. Fowler, Carolyn C. Haass, Presentation Slides: Overview Presentation Steve R. Reese NWMI-005-R Safety Panel 1: Ralph A. Butler, Northwest Medical Isotopes, LLC Michael R. Corum, Gary L. Dunford, Presentation Slides: Safety 1 Presentation Carolyn C. Haass, Steve R. Reese NWMI-006-R Safety Panel 2: Michael R. Corum, Northwest Medical Isotopes, LLC Gary L. Dunford, Carolyn C. Haass, Presentation Slides: Safety 2 Presentation Steve R. Reese NWMI-007-R Environmental Panel: Michael R. Northwest Medical Isotopes, LLC Corum, Gary L. Dunford, Carolyn C. Presentation Slides: Environmental Haass, Steve R. Reese Presentation NWMI-008 Letters of Support: U.S. Senators Federal, State of Missouri, City of Columbia, Ron Wyden and Claire McCaskill; and Boone County letters of support for the Boone County Commissioner construction and operation of the Northwest Dan Atwill; Manager, City of Medical Isotopes, LLC Radioisotope Columbia, Missouri, Mike Mathis; Production Facility Missouri Department of Economic Development, Terrance M. Maglich, Project Manager NWMI-009 Missouri Department of Natural Clean Water Act Section 401 Water Quality Resources Letter to Northwest Medical Certification of Northwest Medical Isotopes, Isotopes, LLC, dated September 15, LLC Facility in Boone County, NUREG-2017 2209/CEK007189 Exhibit List (Docket No. 50-609-CP) 2

Exhibit List-R Exhibit Panel Number/

Number Sponsoring Witness(es) Document Description/Title NWMI-010 Northwest Medical Isotopes, LLC Exemption Request Pursuant to 10 CFR Letter (NWMI-LTR-2017-016) to U.S. 70.17, from Requirement of 10 CFR Nuclear Regulatory Commission, dated 70.21(f), Filing, for Northwest Medical December 18, 2017 Isotopes, LLC Radioisotope Production Facility, dated December 18, 2017 NWMI-011-R Carolyn C. Haass Applicants Pre-Filed Testimony of Carolyn C. Haass for the Mandatory Hearing on Uncontested Issues for the Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility Respectfully submitted, Executed in Accord with 10 C.F.R. § 2.304(d)

Carolyn Digitally signed by Carolyn C Haass C Haass Date: 2018.01.16 13:27:56 -07'00' Signed (electronically) by Carolyn C. Haass Carolyn C. Haass Northwest Medical Isotopes, LLC - Chief Operating Officer 815 NW 9th Ave, Suite 256 Corvallis, OR 97330 Phone: 509-430-6921 Email: carolyn.haass@nwmedicalisotopes.com Dated in Denver, Colorado this 16th day of January 2018 Exhibit List (Docket No. 50-609-CP) 3

Exhibit List-R UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION

)

In the Matter of ) Docket No. 50-609-CP

)

NORTHWEST MEDICAL ISOTOPES, LLC )

)

(Medical Radioisotope Production Facility) ) January 16, 2018

)

CERTIFICATE OF SERVICE I hereby certify that on this date, a copy of the Exhibit List (Revision 1), Northwest Medical Isotopes, LLC, Evidentiary Hearing and Exhibits NWMI-001-R through NWMI-007-R and NWMI-011-R were submitted through the NRC E-filing system.

Exhibits NWMI-007, NWMI-008, and NWMI-009 have not been revised since the original submission on December 29, 2017.

Respectfully submitted, Executed in Accord with 10 C.F.R. § 2.304(d)

Carolyn C Digitally signed by Carolyn C Haass Haass Date: 2018.01.16 13:28:16 -07'00' Signed (electronically) by Carolyn C. Haass Carolyn C. Haass Northwest Medical Isotopes, LLC - Chief Operating Officer 815 NW 9th Ave, Suite 256 Corvallis, OR 97330 Phone: 509-430-6921 Email: carolyn.haass@nwmedicalisotopes.com Dated in Denver, Colorado this 16thday of January 2018 Certificate of Service (Docket No. 50-609-CP)